CHRS

COHERUS ONCOLOGY INC

CHRS·19249H103·US·Common Stock·Healthcare - Biotechnology-13D/G

CHRS (COHERUS ONCOLOGY INC) is held by 87 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($16.8M), VANGUARD CAPITAL MANAGEMENT LLC ($8.3M), GEODE CAPITAL MANAGEMENT, LLC ($5.2M). Net institutional sentiment: Mixed.

87
Holders
(8 Elite)
$62M
Total Value
61% (82)
Consensus
50 buying - 32 selling
13F: Insider & Congress: Updated regularly
CHRS

Smart Money Verdict

View all
Loading verdict
Held by 87 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders May 28, 2025 · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.5.8%Jul 27, 2026
ActivistTGTimothy G. Youngquist 2020 Irrevocable Trust8.3%May 15, 2026
ActivistTAThomas A. Satterfield, Jr.4.6%Apr 29, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12M(+15.8%)$16.8M0.0%-2.40%
33
Increased
5.9M(+9.1%)$8.3M0.0%-10.99%
30
Increased
3.7M(+18.1%)$5.2M0.0%-77.20%
32
Increased
2.4M(+2.4%)$3.3M0.0%-51.94%
27
Decreased
2.3M(-1.9%)$3.2M0.0%-9.49%
0
Decreased
1.7M(-23.0%)$2.4M0.0%-12.12%
0
Decreased
1.7M(-0.7%)$2.4M0.0%-48.83%
0
Increased
1.3M(+10.3%)$1.9M0.0%+1.61%
28
Increased
1.2M(+6.2%)$1.7M0.0%-75.59%
27
Decreased
1.1M(-22.1%)$1.6M0.0%+22.30%
0
Increased
1.1M(+23.6%)$1.6M0.0%-82.10%
31
Increased
1M(+7.0%)$1.4M0.0%-11.24%
27
Unchanged
899,999$1.3M0.0%+2.84%
0
Increased
883,454(+46.1%)$1.2M0.0%-7.71%
34
Increased
760,358(+39.0%)$1.1M0.0%-3.27%
33
Decreased
602,075(-13.5%)$842,9050.0%-8.79%
0
Increased
563,056(+69.8%)$788,2780.0%-0.96%
37
Increased
395,600(+22.1%)$553,8400.0%+14.46%
29
Increased
353,922(+5.5%)$495,4910.0%-46.13%
17
Increased
319,687(+12.2%)$447,5630.0%-85.16%
27

Showing 1-20 of 94

1 / 5
CHRSCHRSCOHERUS ONCOLOGY INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used